Evelo Biosciences, Inc. - Common Stock (NQ:EVLO)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 11, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Evelo Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 31, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 26, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 25, 2022

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Rises 150 Points; Emclaire Financial Shares Spike Higher ↗

March 24, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq composite gaining over 150 points on Thursday. The Dow traded up 0.76% to 34,621.33 while the NASDAQ rose 1.19...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 04, 2022

On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap...

Via Benzinga

88 Biggest Movers From Yesterday ↗

May 26, 2022

Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) shares jumped 118.2% to close at $0.2950 on Wednesday as the company announced it increased retail distribution across Canada with Loblaw...

Via Benzinga

Evelo Biosciences: Q1 Earnings Insights ↗

May 12, 2022

Evelo Biosciences (NASDAQ:EVLO) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Read Why Did Evelo Discontinue EDP1867 Atopic Dermatitis Program ↗

April 14, 2022

Via Benzinga

50 Stocks Moving In Wednesday's Mid-Day Session ↗

May 25, 2022

Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) gained 178.3% to $0.3762 as the company announced it increased retail distribution across Canada with Loblaw Companies.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 24, 2022

Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) stock increased by 26.3% to $1.73 during Thursday's regular session. The current volume of 55.2 million shares is 5751.8...

Via Benzinga

Evelo Biosciences Shares Gain After Positive Data On Faster Release EDP1815 Capsule, Q4 Earnings ↗

March 24, 2022

In the Q4 earnings release,Evelo Biosciences Inc(NASDAQ: EVLO) shared results from an ongoing Phase 1 single-center trial in ...

Via Benzinga

80 Biggest Movers From Yesterday ↗

May 04, 2022

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 93.1% to close at $6.45 on Tuesday on above-average volume. XORTX Therapeutics Inc. (NASDAQ: XRTX) gained 59.1% to...

Via Benzinga

55 Biggest Movers From Friday ↗

April 25, 2022

Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 100.9% to close at $2.27 on Friday. Vallon Pharmaceuticals engaged Ladenburg Thalmann & Co Inc to evaluate...

Via Benzinga

Mid-Day Market Update: Dow Surges 250 Points; LiqTech International Shares Slide ↗

March 24, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones jumping 250 points on Thursday. The Dow traded up 0.75% to 34,617.38 while the NASDAQ rose 1.08% to 14,072.31...

Via Benzinga

63 Biggest Movers From Yesterday ↗

March 25, 2022

Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares gained 39.1% to close at $1.05 on Thursday. The company recently said its CFO Bruce Colwill will retire. Global Internet...

Via Benzinga

34 Stocks Moving In Thursday's Mid-Day Session ↗

March 24, 2022

Gainers JX Luxventure Limited (NASDAQ: LLL) shares jumped 37.7% to $4.64. Emclaire Financial Corp (NASDAQ: EMCF) shares climbed 32.8% to $38.35 after the company and...

Via Benzinga

The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL ↗

March 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Evelo Biosciences: Q4 Earnings Insights ↗

March 24, 2022

Evelo Biosciences (NASDAQ:EVLO) reported its Q4 earnings results on Thursday, March 24, 2022 at 06:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

Evelo Biosciences's Earnings Outlook ↗

March 23, 2022

Evelo Biosciences (NASDAQ:EVLO) is set to give its latest quarterly earnings report on Thursday, 2022-03-24. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings ↗

March 20, 2022

Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment...

Via Benzinga

Earnings Scheduled For March 24, 2022 ↗

March 24, 2022

Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its fourth quarter. • Pioneer Muni High Inc (NYSE:MAV) is expected to...

Via Benzinga

Evelo Biosciences Q4 2021 Earnings Conference Call On March 24, 2022 At 08:30 AM ET ↗

March 18, 2022

Evelo Biosciences (NASDAQ:EVLO) will host a conference call at 08:30 AM ET on March 24, 2022, to discuss Q4 2021 earnings results. How to Attend Evelo Biosciences (EVLO)...

Via Benzinga

Evelo Biosciences' Psoriasis Candidate Shows Reductions In Inflammatory Cytokines ↗

February 07, 2022

Evelo Biosciences Inc (NASDAQ: EVLO) has announced the results of immunological biomarker analyses from its previously reported Phase 2 trial of orally-dosed EDP1815 in mild and moderate psoriasis.

Via Benzinga

Global Multiple Sclerosis Drugs Market Expected to Reach $41.99 Billion in 2028

February 03, 2022

Palm Beach, FL –– February 3, 2022 – FinancialNewsMedia.com News Commentary – Multiple Sclerosis (MS) is an immune-mediated disease of the central nervous system. It is characterized by demyelination,...

Via FinancialNewsMedia

34 Stocks Moving In Monday's Mid-Day Session ↗

December 27, 2021

Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares jumped 69.6% to $9.19 after the company announced a strategic collaboration with Stryker Corporation to develop the LIBERTY...

Via Benzinga

52 Weeks High And Low Article ↗

January 11, 2022

Stocks that Broke Yearly Lows Tuesday Morning During Tuesday's morning trading, 87 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Highs And Lows: 10x...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 23, 2021

Gainers Pasithea Therapeutics (NASDAQ:

Via Benzinga

54 Biggest Movers From Thursday ↗

December 27, 2021

Gainers 22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products that help reduce exposure to and consumption of...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 10, 2021

Gainers Valneva (NASDAQ:VALN) shares increased by 24.51% to $50.34 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.6...

Via Benzinga

64 Biggest Movers From Yesterday ↗

November 02, 2021

Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.